Scientist developing aptamers into novel diagnostics and therapeutics @ Deakin Uni, Australia. President of International Society on Aptamers (INSOAP)
Melbourne
Joined November 2013
- Tweets923
- Following280
- Followers446
- Likes701
Pinned Tweet
Being able to enter the brain non-disruptively to specifically target certain populations of cells is the next step in delivering better QoL to patients #aptamers @OTSociety @JAptamers @AptamerSociety Made even better by separate validation in this study pubs.acs.org/doi/10.1021/jac…
I'm very excited to present our latest paper showing targeted drug delivery across the blood brain barrier and specifically to cancer cells in the brain #inmice @DeakinMedicine @deakinresearch @CMMR_Deakin liebertpub.com/doi/10.1089/n…
If you're attending in person for next week's conference, please remember to use #AptOx23 and tag @AptamerSociety in your tweets.
View final #AptOx23 agenda: libpubmedia.co.uk/aptamers-2…
The conference is only 3 weeks away: 25+ oral presentations including two keynote talks & hours of networking.
Poster abstract deadline: 15th March
Only a few place left for in-person attendance, so register soon.
#Aptamers
We're asking for EOIs for an APAC Aptamers conference in November. If you're interested in attending, please fill out this EOI aus01.safelinks.protection.o…
We now have a Australia and New Zealand aptamer group on LinkedIn so if you are currently working down under with aptamers, please join. If we get enough members, we may look at some activities here @AptamerSociety linkedin.com/groups/14151444…
Anybody out in the Twitterverse using, prescribing or developing cancer therapeutics that wants to have a quick chat about what they'd like to see in a new drug? @cogno_trials @AptamerSociety
A good article by a non-aptamer specialist who was blown away by my talk at a recent conference #aptamers @JAptamers @AptamerSociety
labonline.com.au/content/lif…
We did a JoVE. Paper is out and leads you through how to use aptamers in immunophenotyping assays instead of antibodies. Video coming soon. jove.com/t/64304
Off to buy a lotto ticket after satisfying Reviewer #2 in the first round on a paper! More info to come soon but kind of builds on the work we've done with our bifunctional aptamers :)
liebertpub.com/doi/full/10.1…
The lastest edition of INSOAP Times is out if you want so see what's happening with aptamers at the moment @AptamerSociety @JAptamers @mmckeague @MalikaratchyLab
aptamersociety.org/business/…
Looking forward to next year's conference. Save the date!#OzNanomed I'm encouraged that #aptamers were mentioned every day 😊
A special thank you to Kimberly who ensures we all get looked after at #OzNanomed
Excited to present in person at #oznanomed this afternoon on how we get the brain to take its medicine for targeted cancer therapy
Very excited to present at this online European conference to share how #aptamers can cross the blood brain barrier. There's still time to register etkinlik.marmara.edu.tr/ambc…
Given the recent article on 'A golden age for cancer research' in Nature on antibody drug conjugates, it's timely to repost this #aptamer @deakinresearch @OTSociety @sciam @NatureMedicine
liebertpub.com/doi/full/10.1…
This is an absolutely fantastic application of aptamers. A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk science.org/doi/10.1126/scit… @AptamerSociety
The hybrid Aptamer Symposium has been fantastic with great applications presented. The keynote from Larry Gold is going to be the topic of future lectures. Missed it? We will be writing it up in the newsletter and conference proceedings paper #AptaOx22 @AptamerSociety
The last speaker of #AptaOx22 is Vipasha Sharma talking about Rationally Truncated high affinity Aptamer based Electrochemical Detection of Stress Hormone on Graphene Quantum Dots Modified Screen Printed Electrodes @AptamerSociety
The penultimate talk of the conference is Auriane Guitton-Auberty discussing aptamer-target crosslinks formation #AptaOx22 @AptamerSociety
Halfway through the last session and next up is Meihua Gong talking about a new tool to purify methylated peptide from bacteria in order to study bacterial mechanosensing #AptaOx22 @AptamerSociety
Next up is Jordan Cossu talking about selection and characterization of single-stranded DNA aptamers against the CD-20 antigen #AptaOx22 @AptamerSociety